| European Respiratory Society guidelines for the management of adult bronchiectasis E Polverino, PC Goeminne, MJ McDonnell, S Aliberti, SE Marshall, ... European Respiratory Journal 50 (3), 2017 | 1211 | 2017 |
| Tezacaftor–ivacaftor in residual-function heterozygotes with cystic fibrosis SM Rowe, C Daines, FC Ringshausen, E Kerem, J Wilson, E Tullis, N Nair, ... New England Journal of Medicine 377 (21), 2024-2035, 2017 | 536 | 2017 |
| Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research AT Hill, CS Haworth, S Aliberti, A Barker, F Blasi, W Boersma, ... European Respiratory Journal 49 (6), 2017 | 375 | 2017 |
| Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open … DE Griffith, G Eagle, R Thomson, TR Aksamit, N Hasegawa, K Morimoto, ... American journal of respiratory and critical care medicine 198 (12), 1559-1569, 2018 | 298 | 2018 |
| The EMBARC European Bronchiectasis Registry: protocol for an international observational study JD Chalmers, S Aliberti, E Polverino, M Vendrell, M Crichton, M Loebinger, ... ERJ open research 2 (1), 2016 | 221 | 2016 |
| Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration S Aliberti, S Masefield, E Polverino, A De Soyza, MR Loebinger, ... European Respiratory Journal 48 (3), 632-647, 2016 | 214 | 2016 |
| Bronchiectasis-associated hospitalizations in Germany, 2005–2011: a population-based study of disease burden and trends FC Ringshausen, A de Roux, MW Pletz, N Hämäläinen, T Welte, ... PloS one 8 (8), e71109, 2013 | 205 | 2013 |
| Bronchiectasis in Germany: a population-based estimation of disease prevalence FC Ringshausen, A de Roux, R Diel, D Hohmann, T Welte, J Rademacher European Respiratory Journal 46 (6), 1805-1807, 2015 | 166 | 2015 |
| Microbiological and clinical outcomes of treating non-Mycobacterium avium complex nontuberculous mycobacterial pulmonary disease: a systematic review and meta-analysis R Diel, F Ringshausen, E Richter, L Welker, J Schmitz, A Nienhaus Chest 152 (1), 120-142, 2017 | 161 | 2017 |
| Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations S Aliberti, PC Goeminne, AE O'Donnell, TR Aksamit, H Al-Jahdali, ... The Lancet Respiratory Medicine 10 (3), 298-306, 2022 | 160 | 2022 |
| Prevalence of nontuberculous mycobacterial pulmonary disease, Germany, 2009–2014 FC Ringshausen, D Wagner, A de Roux, R Diel, D Hohmann, L Hickstein, ... Emerging infectious diseases 22 (6), 1102, 2016 | 154 | 2016 |
| Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an … M Griese, S Costa, RW Linnemann, MA Mall, EF McKone, D Polineni, ... American journal of respiratory and critical care medicine 203 (3), 381-385, 2021 | 152 | 2021 |
| Risk assessment of tuberculosis in contacts by IFN-γ release assays. A Tuberculosis Network European Trials Group study JP Zellweger, G Sotgiu, M Block, S Dore, N Altet, R Blunschi, M Bogyi, ... American journal of respiratory and critical care medicine 191 (10), 1176-1184, 2015 | 141 | 2015 |
| Burden of non-tuberculous mycobacterial pulmonary disease in Germany R Diel, J Jacob, N Lampenius, M Loebinger, A Nienhaus, KF Rabe, ... European Respiratory Journal 49 (4), 2017 | 140 | 2017 |
| Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC) JD Chalmers, E Polverino, ML Crichton, FC Ringshausen, A De Soyza, ... The Lancet Respiratory Medicine 11 (7), 637-649, 2023 | 134 | 2023 |
| Microbiologic outcome of interventions against Mycobacterium avium complex pulmonary disease: a systematic review R Diel, A Nienhaus, FC Ringshausen, E Richter, T Welte, KF Rabe, ... Chest 153 (4), 888-921, 2018 | 125 | 2018 |
| Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles SY Graeber, C Vitzthum, ST Pallenberg, L Naehrlich, M Stahl, A Rohrbach, ... American journal of respiratory and critical care medicine 205 (5), 540-549, 2022 | 117 | 2022 |
| Interferon-gamma release assays for the tuberculosis serial testing of health care workers: a systematic review FC Ringshausen, A Schablon, A Nienhaus Journal of Occupational Medicine and Toxicology 7, 1-9, 2012 | 115 | 2012 |
| Predictors of persistently positive Mycobacterium-tuberculosis-specific interferon-gamma responses in the serial testing of health care workers FC Ringshausen, A Nienhaus, A Schablon, S Schlösser, ... BMC infectious diseases 10, 1-11, 2010 | 108 | 2010 |
| Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers FC Ringshausen, A Nienhaus, J Torres Costa, H Knoop, S Schlösser, ... Clinical and Vaccine Immunology 18 (7), 1176-1182, 2011 | 94 | 2011 |
Michael LoebingerConsultant Respiratory Medicine, Royal Brompton Hospital在 rbht.nhs.uk 的电子邮件经过验证
